Programas clínicos
¡Próximamente!

Barrett’s Esophagus

Barrett’s Esophagus Explained

Barrett’s esophagus occurs when chronic acid exposure from GERD causes the normal squamous lining of the lower esophagus to be replaced with specialized intestinal-type cells (intestinal metaplasia). Most people with Barrett’s have ongoing reflux symptoms, but some have minimal or no heartburn.

While the overall risk of progressing to esophageal adenocarcinoma is low each year, it is higher than in the general population. For this reason, many patients benefit from regular endoscopic surveillance and aggressive reflux control. In certain cases with dysplasia, endoscopic ablation or resection may be recommended.

Síntomas

Barrett’s itself usually does not cause unique symptoms; most people experience symptoms of chronic GERD such as heartburn and regurgitation, or they may be found to have Barrett’s incidentally during endoscopy.

Los síntomas incluyen:
Typical GERD symptoms (heartburn, regurgitation, sour taste)
Chest discomfort or pain related to reflux
Difficulty swallowing in some patients
Many patients have no additional symptoms beyond their usual reflux

Cuándo llamar

Call the office if you have Barrett’s esophagus and experience worsening reflux, new or progressive trouble swallowing, unexplained weight loss, or changes in your usual symptoms. These changes may prompt earlier evaluation.

Seek emergency care for vomiting blood, black or tarry stools, severe chest pain, or sudden difficulty swallowing or breathing. These can be signs of bleeding or other serious complications and should be evaluated urgently.

Evaluación y pruebas
Manejo y tratamiento

Barrett’s is diagnosed with upper endoscopy and biopsies that confirm intestinal metaplasia in the lower esophagus. After diagnosis, surveillance schedules are based on the presence and grade of dysplasia, along with individual risk factors.

Endoscopic visualization of salmon-colored mucosa extending above the stomach into the esophagus
Systematic biopsies from the affected segment to confirm intestinal metaplasia and assess for dysplasia
Risk stratification based on segment length, histology, and patient risk factors
Ongoing surveillance endoscopy at intervals guided by current guidelines and findings
Assessment and management of underlying reflux (GERD)

Management focuses on controlling reflux, reducing cancer risk, and monitoring for progression. This includes acid suppression, lifestyle changes, and regular endoscopic surveillance. In patients with dysplasia, endoscopic ablation or resection can remove abnormal tissue and further reduce cancer risk.

Aggressive reflux control with lifestyle modification and PPIs
Adherence to an individualized endoscopic surveillance schedule
Endoscopic therapies (e.g., radiofrequency ablation, endoscopic mucosal resection) for patients with dysplasia
Discussion of risks and benefits of ongoing surveillance, especially in older or frail patients
Education about symptom monitoring and the importance of long-term follow-up
Esta información tiene únicamente fines educativos generales y no constituye un diagnóstico ni un consejo médico personalizado. No sustituye la consulta con su propio profesional sanitario. Siga siempre las recomendaciones específicas que le haya dado su equipo médico. Si presenta síntomas urgentes o que empeoran, póngase en contacto con su profesional sanitario o acuda inmediatamente a urgencias.

De un vistazo

HeartburnTrouble swallowing

Ayudando a Idaho a sentirse mejor desde 1976.

La información de este sitio web tiene fines exclusivamente educativos y no sustituye el asesoramiento médico.

Si tienes una emergencia, llama al 911.
© 2026 Idaho Gastroenterology Associates. Todos los derechos reservados.
Sitio web diseñado por:
ADVANTAGE ADVERTISING, S.L.
LinkedIn Facebook Pinterest YouTube rss Twitter Instagram facebook-en blanco rss-blank linkedin-en blanco Pinterest YouTube Twitter Instagram